BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 15, 2026
See today's BioWorld
Home
» Avalon's Lichter: 'Laid-Back' Savvy Keeps Deal Flow Strong
To read the full story,
subscribe
or
sign in
.
Avalon's Lichter: 'Laid-Back' Savvy Keeps Deal Flow Strong
April 16, 2013
By
Randy Osborne
When it comes to getting venture capital (VC) deals done, the science and the financial terms naturally take center stage, but the personalities of the players need to mesh, too, for the best outcomes.
BioWorld